Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)

Market Cap	3.86B
Revenue (ttm)	641.59M
Net Income (ttm)	155.96M
Shares Out	198.24M
EPS (ttm)	0.78
PE Ratio	24.90
Forward PE	21.16
Dividend	0.27 (1.39%)
Ex-Dividend Date	Jun 20, 2024

Volume	2,019,249
Average Volume	2,145,810
Open	19.35
Previous Close	19.27
Day's Range	19.27 - 19.57
52-Week Range	18.22 - 29.20
Beta	0.48
RSI	46.28
Earnings Date	Apr 18, 2025

About SHA:603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. researches, develops, and sells Chinese medicine products. It offers ganoderma lucidum spore powder, dendrobium officinale and ganoderma lucidum extract, dendrobium officinale granules, saffron extract, crocus sativus, and other health products. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is based in Jinhua, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1997
• Employees: 1,118
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603896

Financial Performance

In 2024, SHA:603896's revenue was 691.68 million, a decrease of -11.81% compared to the previous year's 784.35 million. Earnings were 174.71 million, a decrease of -31.34%.